ScholarIQanswers from OpenAlex
Candiolo Cancer Institute
InstitutionResearch output, impact & collaborations
Candiolo Cancer Institute is a institution indexed in ScholarIQ from OpenAlex.
What is known about Candiolo Cancer Institute?
ScholarIQrecord summary
Candiolo Cancer Institute is a research organisation in Candiolo, IT. OpenAlex records 6,245 works and 788,783 citations for it. 829 researchers list it as their most recent affiliation.
How many works does Candiolo Cancer Institute have?
ScholarIQindexed works
Candiolo Cancer Institute has 6,245 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Candiolo Cancer Institute have?
ScholarIQcitation count
Candiolo Cancer Institute has 788,783 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at Candiolo Cancer Institute?
ScholarIQresearcher count
Candiolo Cancer Institute has 829 researchers in the ScholarIQ index.
What is the average h-index at Candiolo Cancer Institute?
ScholarIQavg h-index
Candiolo Cancer Institute has an average h-index of 76 in OpenAlex.
What is the ROR of Candiolo Cancer Institute?
ScholarIQror
The ROR for Candiolo Cancer Institute is on the source record.
What is the OpenAlex record for Candiolo Cancer Institute?
ScholarIQopenalex
The OpenAlex for Candiolo Cancer Institute is on the source record.
Who are the most-cited researchers behind Candiolo Cancer Institute?
ScholarIQtop researchers by citations
What are the most-cited papers on Candiolo Cancer Institute?
ScholarIQmost cited works
Distinct Populations of Cancer Stem Cells Determine Tumor Growth and Metastatic Activity in Human Pancreatic Cancer
Patrick Hermann, Stephan Huber, Tanja Herrler, Alexandra Aicher, Joachim W. Ellwart, Markus Guba, Christiane J. Bruns, Christopher Heeschen
The 2019 World Health Organization classification of tumours of the breast
Puay Hoon Tan, Ian O. Ellis, Kimberly H. Allison, Edi Brogi, Stephen B. Fox, Sunil R. Lakhani, Alexander J. Lazar, Elizabeth A. Morris, Ayşegül A. Şahin, Roberto Salgado, Anna Sapino, Hironobu Sasano, Stuart J. Schnitt, Christos Sotiriou, Paul van Diest, Valerie A. White, Dilani Lokuhetty, Ian A. Cree, for the WHO Classification of Tumours Editorial Board
Reversible and adaptive resistance to BRAF(V600E) inhibition in melanoma
Chong Sun, Liqin Wang, Sidong Huang, Guus J.J.E. Heynen, Anirudh Prahallad, Caroline Robert, John B.A.G. Haanen, Christian U. Blank, Jelle Wesseling, Stefan M. Willems, Davide Zecchin, Sebastijan Hobor, Prashanth Kumar Bajpe, Cor Lieftink, Christina Mateus, Stéphan Vagner, Wipawadee Grernrum, Ingrid Hofland, Andreas Schlicker, Lodewyk F.A. Wessels, Roderick L. Beijersbergen, Alberto Bardelli, Federica Di Nicolantonio, Alexander M.M. Eggermont, René Bernards
Vorasidenib in IDH1- or IDH2-Mutant Low-Grade Glioma
Ingo K. Mellinghoff, Martin J. van den Bent, Deborah T. Blumenthal, Mehdi Touat, Katherine B. Peters, Jennifer Clarke, Joe Mendez, Shlomit Yust‐Katz, Liam Welsh, Warren Mason, François Ducray, Yoshie Umemura, Burt Nabors, Matthias Holdhoff, Andreas F. Hottinger, Yoshiki Arakawa, Juan Manuel Sepúlveda-Sánchez, Wolfgang Wick, Riccardo Soffietti, James Perry, Pierre Giglio, Macarena de la Fuente, Elizabeth A. Maher, Steven Schoenfeld, Dan Zhao, Shuchi S. Pandya, Lori Steelman, Islam Hassan, Patrick Y. Wen, Timothy F. Cloughesy
Follicular Lymphoma International Prognostic Index 2: A New Prognostic Index for Follicular Lymphoma Developed by the International Follicular Lymphoma Prognostic Factor Project
Massimo Federico, Monica Bellei, Luigi Marcheselli, Stefano Luminari, Armando López‐Guillermo, Umberto Vitolo, Barbara Pro, Stefano Pileri, Alessandro Pulsoni, Pierre Soubeyran, Sergio Cortelazzo, Giovanni Martinelli, Maurizio Martelli, Luigi Rigacci, Luca Arcaini, Francesco Di Raimondo, Francesco Merli, Elena Sabattini, Peter McLaughlin, Philippe Solal‐Céligny
How much of the research on Candiolo Cancer Institute is open access?
ScholarIQopen access share
90%OPEN ACCESS